Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20845258 | 0.97 | PDK2 (0.34) | PDK2CYP19A1KDM4EGLAGAA | |
| SCHEMBL20845112 | 0.97 | TSHR (0.33) | PDK2CYP19A1KDM4EGLAGAA | |
| SCHEMBL20845260 | 0.96 | PDK2 (0.31) | PDK2CYP19A1CYP3A4CYP2C9 | |
| SCHEMBL20845257 | 0.95 | PDK2 (0.34) | PDK2CYP19A1KDM4EGLAGAA | |
| SCHEMBL20845109 | 0.95 | PDK2 (0.34) | PDK2CYP19A1KDM4EGLAGAA | |
| SCHEMBL20845255 | 0.94 | CYP3A4 (0.31) | PDK2CYP19A1ALDH1A1POLBMAPT | |
| SCHEMBL20845254 | 0.93 | MEN1 (0.33) | KDM4EGLAALDH1A1MAPT | |
| SCHEMBL20845253 | 0.93 | PDK2 (0.31) | PDK2CYP19A1CYP3A4 | |
| SCHEMBL20845106 | 0.92 | PDK2 (0.33) | PDK2KDM4EALDH1A1POLBMAPT | |
| SCHEMBL20222704 | 0.91 | PDK2 (0.37) | PDK2CYP19A1KDM4EGLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SCO2, AOX1, ORC3 | PDK2 2247/4885CYP19A1 380/4885KDM4E 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.